Skip to main content

Table 4 Patient characteristics - hip

From: Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis

Study, Year

Number of patients TXA/C

Gender distribution % male TXA /C

Mean age TXA,C (SD or range)

Mean weight (kg) – TXA, C (SD or Range)

TBL – TXA,C (mL) (SD)

P Value

Patient requiring allogeneic transfusions (TXA, C)

P Value

 

TXA

C

TXA

C

TXA

C

TXA

C

TXA

C

 

TXA

C

 

Ekbäck, 2000[28]

20

20

45

55

66.4 (9.0)

65.6 (8.8)

81.1 (13)

76.8 (13)

1130 (400)

1770 (523)

<0.001

5

5

N/R

Benoni, 2000[29]

20

19

30

58

69.5 (10)

68 (10)

76 (14),

77 (11)

990 â—Š(210 ),

950 â—Š(162.5)

N/R

45

79

0.05

Benoni, 2001[33]

18

20

50

50

66 (9.5)

68 (9.4)

79 (16)

78 (17)

759 (275.8†)

996 (398†)

0.03

22

40

0.2

Husted, 2003[25]

20

20

35

30

65

67

N/R

814 (1323.8†)

1231 (1692.7†)

0.001

10

35

0.04

Yamasaki, 2004[41]

20

20

95

90

55.5 (14.2)

61.2 (6.9)

52.6 (11.5)

54.5 (8.7)

1350 (477)

1667 (401)

<0.05

0

0

N/R

Garneti, 2004[14]

25

25

N/R

69.6 (11.99)

67.6 (11.4)

N/R

1443 (809)

1340 (665)

0.822

64

56

N/R

Lemay, 2004[34]

20

19

60

68

59.7 (10.3)

53.6 (12.8)

80.1 (15.7)

74.7 (14.1)

1308 (462)

1469 (405)

N/R

0

42

0.0012

Johansson, 2005[26]

47

53

53

53

69 (7)

69 (7)

81 (16)

78 (13)

969 (434)

1324 (577)

<0.001

17

43

0.009

Niskanen, 2005[30]

19

20

32

35

66 (9.1)

65 (8.2)

80 (19)

82 (14)

792 (390.1†)

1102 (485.2 †)

0.03

26

40

0.3

Claeys, 2007[32]

20

20

25

35

73 (8)

68 (11)

76 (15)

72 (16)

801 (244)

1038 (289)

0.013

5

30

<0.05

Kazemi, 2010[8]

32

32

72

63

46.6 (16.2)

45.4 (17.2)

72.1 (10.4),

69.9 (11.1)

1024 (544)

1399 (587)

0.024

N/R

N/R

Malhotra, 2011[20]

25

25

40

48

52.6 (39–72)

54.7 (40–71)

80.2 (58–100)

81.9 (62–98)

410 (300–510) – range

615 (515–750) –range

<0.5

24

72

N/R

McConnell, 2011[38]

22

22

32

41

N/R

N/R

N/R

N/R

930 (399†)

1200 (469†)

0.02

0

0

N/R

Imai, 2012[39] *

24, 20, 25, 26

22

17, 20, 16, 15

23

64.4 (49–74), 62.2 (50–85), 63.3 (47–80), 63.3 (48–81)

60.2 (54–72)

55.9 (44–86), 54.1 (40–76), 54.1 (41–70), 53.8 (44–73)

56.3 (47–80)

649, 566, 388, 418**

1026**

N/R

0

0

N/R

  1. â—ŠSum of perioperative and drain medians7, † - Calculated from 95% CI, C – Control group, TXA – Tranexamic group, SD – Standard Deviation, DVT – deep venous thrombosis, N/R – not reported. *Patients received 1 g TXA 10 minutes prior to skin closure, 10 minutes prior to skin closure and 6 hrs later, 10 minutes prior to surgery, 10 minutes prior to surgery and 6 hrs later, respectively. ** Intra-op + post-op.